A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza

N/ACompletedNCT01192958

Public Health England

Overview

At present influenza immunity can only be reliably confirmed by a blood test. This test is invasive for the patient. This study is intended to validate an oral fluid/saliva antibody test for the variant Swine Influenza H1N1. If such a test were available, this painless and non invasive test will improve direct clinical care to an individual as well as significantly help guide future public health management of the pandemic.

Study Type

OBSERVATIONAL

Conditions

H1N1 Virus

Eligibility

Sex: ALLMin age: 6 MonthsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Participants of the clinical service evaluation of novel H1N1v vaccine * First or second blood sample for the clinical service evaluation successfully collected Exclusion Criteria: * Withdrawn from clinical service evaluation of novel H1N1v vaccine * Second blood sample for the clinical service evaluation not collected.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.